• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    OrangeTwist Announces Strategic Alliance with SBC Medical Group Holdings and Expansion to 24 Locations Across 6 States to Support Long-Term Growth Initiatives

    1/7/26 9:35:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care
    Get the next $SBC alert in real time by email

    OrangeTwist, a leading U.S. med spa platform delivering cutting-edge aesthetic and wellness treatments through a hospitality-driven clinical experience, has announced a strategic alliance and minority investment with SBC Medical Group Holdings Incorporated (NASDAQ:SBC) as part of its accelerated national growth strategy. The collaboration marks a significant milestone for OrangeTwist, enabling new clinical, operational, and technological synergies with a global leader in medical services and clinic operations.

    In conjunction with this announcement, OrangeTwist has acquired six additional med spa locations in Colorado and Nevada, expanding its footprint to 24 locations across 6 states, including California, Texas, Washington, Nevada, Colorado, and New Jersey. The expansion reinforces OrangeTwist's mission to scale its clinically grounded, client-centric model of non-invasive aesthetic care nationwide.

    "We are thrilled to deepen our strategic partnership with SBC Medical Group Holdings while expanding our presence in high-growth markets," said Robert Settembro, CEO of OrangeTwist. "This next chapter allows us to bring exceptional aesthetic experiences to more communities while leveraging SBC's global expertise. We remain focused on high-quality care, best-in-class providers, and innovative services that continue to differentiate OrangeTwist in a rapidly growing aesthetic landscape."

    Through the alliance, OrangeTwist and SBC Medical will collaborate on clinical protocol development, advanced technology integration, and operational scalability, positioning the company for accelerated market leadership and long-term strategic growth across both domestic and international markets.

    OrangeTwist is backed by leading private equity firms Hildred and Athyrium Capital Management, providing institutional support for continued organic expansion, strategic acquisitions, and long-term platform growth.

    "We believe the U.S. aesthetic market represents a compelling growth opportunity," said Stephen Hallenbeck, Partner at Hildred. "We believe OrangeTwist's differentiated model, combined with its expanding footprint and strategic partnerships, positions the company for scalable and sustainable growth."

    OrangeTwist remains committed to elevating the standard of non-invasive aesthetic care through continued innovation, premium client experiences, and disciplined expansion.

    About OrangeTwist

    OrangeTwist is a leading provider of medically supervised aesthetic and wellness treatments, delivering real results through innovative, non-invasive services and exceptional client experiences. With 24 locations across 6 states, OrangeTwist offers a comprehensive portfolio of injectable, energy-based, and wellness treatments supported by strong clinical oversight and best-in-class operational systems.

    For more information, visit www.orangetwist.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260107405690/en/

    OrangeTwist

    Denise Keeler

    [email protected]

    Get the next $SBC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBC

    DatePrice TargetRatingAnalyst
    3/6/2026$8.00Buy
    BTIG Research
    More analyst ratings

    $SBC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (NASDAQ:SBC), a Japan-based management services organization building a large and growing global aesthetic medical network. In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy. The Q&A highlights several key themes, including: Improving unit economics, with Q4 average revenue per visit increasing 11% year over year to $316, signa

    3/31/26 10:12:55 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Announces Next-Generation Wellness Strategy "SBC Wellness 2.0"

    Pioneering the "Performance Medicine" category for full-scale entry into the longevity market — targeting a global market projected to reach $2 trillion by 2035 SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced "SBC Wellness 2.0," a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323000188/en/SBC Medical Announces Next-Generation Wellness

    3/24/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    SEC Filings

    View All

    SEC Form 10-K filed by SBC Medical Group Holdings Incorporated

    10-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 7:31:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 6:50:43 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    1/5/26 7:00:29 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on SBC Medical Group with a new price target

    BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

    3/6/26 8:35:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SBC Medical Group Holdings Incorporated

    4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    3/10/26 9:54:07 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Yamazaki Miki

    3 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/18/25 4:56:42 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: New insider Aikawa Yoshiyuki claimed ownership of 94,192,433 shares (SEC Form 3)

    3/A - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/9/25 7:00:13 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Leadership Updates

    Live Leadership Updates

    View All

    SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

    3/2/26 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company's strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center

    7/14/25 9:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

    IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of

    7/1/25 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    10/1/24 9:00:18 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/24/24 9:07:03 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/23/24 9:02:53 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Financials

    Live finance-specific insights

    View All

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results

    IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.  Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company's financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remark

    3/13/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 mill

    11/14/25 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care